Our CEO, Noor Shaker, is giving a keynote at Pharma R&D Informatics, Medicinal Chemistry and Cannabinoids Summit. The talk will cover challenges and opportunities for AI in drug discovery and…Read more
We are using Rosalind to support drug discovery efforts of pharmaceutical and biotech companies by extracting insights from their data.
We are involved in a number of research collaborations with leading biotechs and academic institutes to discover novel chemical starting points for challenging targets.
Together with biotechs and academic partners we are working towards developing innovative solutions to drug discovery where AI can be transformative.